← FDA DRUG APPROVALS

FDA ANDA · ANDA075819

AMANTADINE HYDROCHLORIDE

Sponsor: ADAPTIS

APPLICATION
ANDA075819
TYPE
ANDA
ORIGINAL APPROVAL
2002-09-11
LATEST ACTION
2025-07-10
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

AMANTADINE HYDROCHLORIDEDiscontinued
AMANTADINE HYDROCHLORIDE 50MG/5ML · SYRUP · ORAL

Approval history

2025-07-10Labeling · Supplement 3 · standardAP
2012-02-17Labeling · Supplement 2AP
2012-01-10Labeling · Supplement 1AP
2002-09-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →